The association with tumour pEGFR-IR is consistent with the hypothesis that a high activity along the EGFR-Akt signalling pathway facilitates epithelial-mesenchymal transition and thereby an adverse clinical outcome. This evidence concerns the gene AKT1 and neoplasm.